English
Japanese
COVID Hot topics
-
Vaccine Update - Fourth dose for elderly
Finland // 25 March, 2022
Health authorities are recommending a fourth dose for everyone aged 80 years and above...COVID-19
-
COVID-19 Update – Omicron BA.2 accounting for majority of cases
Myanmar // 23 March, 2022
Health authorities are monitoring the spread of cases...COVID-19
-
Trend of new COVID-19 cases declining
Malaysia // 23 March, 2022
Omicron is the dominant variant....COVID-19
-
Vaccine Update – Vaccination eligibility age threshold lowered
Zimbabwe // 22 March, 2022
Health authorities have announced that children aged 12 years and above are now eligible for vaccination...COVID-19
-
First wave of activity
Cook Islands // 21 March, 2022
Community transmission is occurring...COVID-19
-
New COVID-19 vaccine trial launched to evaluate reduced dose booster shots
14 March, 2022
Study into fractionated COVID-19 booster shots announced...COVID-19
-
ECDC Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older
14 March, 2022
ECDC interim report into COVID-19 vaccine effectiveness against severe infection...COVID-19
-
CDC extends mask mandate on public transportation
United States // 11 March, 2022
Revised policy to follow…COVID-19
-
Delta-Omicron recombinant confirmed
11 March, 2022
With cases detected across France, Denmark, Netherlands, UK and US...COVID-19
-
Aspen and Johnson & Johnson agree to manufacture and supply Aspenovax throughout Africa
South Africa // 10 March, 2022
Aspenovax to be manufactured in Africa...COVID-19
-
Record number of new COVID-19 cases
Vietnam // 10 March, 2022
Over 265,000 new locally-acquired cases have been recorded....COVID-19
-
Vaccine update- Fourth dose to be offered to at-risk groups
Spain // 10 March, 2022
Spain will start offering a fourth dose...COVID-19
-
Vaccine Update – Novavax approved for 18 years and above and as a booster shot
Sweden // 10 March, 2022
The Public Health Agency of Sweden has approved Novavax for 18 years and above...COVID-19
-
Pfizer begins Paxlovid trials for individuals aged 6 to 17
United States // 10 March, 2022
Pfizer has launched trials for Paxlovid in under 18 years...COVID-19
-
Zifivax COVID-19 vaccine conditionally approved
China // 09 March, 2022
Manufactured by Anhui Zhifei Longcom BiopharmaceuticalCOVID-19
-
Study: Mild COVID-19 may alter brain structure
08 March, 2022
Structural changes in the brain have been observed in COVID-19 recovered patients with...COVID-19
-
Medicago vaccine approved
Canada // 04 March, 2022
Effective against Omicron variant...COVID-19
-
Oral antiviral Molnupiravir conditionally recommended by WHO to treat COVID-19
03 March, 2022
The conditional approval is for use in adults at high risk of hospitalisation...COVID-19
-
New plan to manage COVID-19 announced
United States // 02 March, 2022
Plan focuses on 4 key goals…COVID-19
-
Vaccine Update – Vaccinations for 5 to 11 years have begun
Japan // 02 March, 2022
Vaccinations for children aged 5 to 11 years with underlying conditions has begun...COVID-19
